The findings will inform a continental report intended to support evidence-based policymaking, strengthen accountability and accelerate efforts to prevent maternal and newborn deaths across Africa.
The initiative comes as scientists intensify efforts to address a major Bundibugyo ebolavirus outbreak, with cases rising rapidly in the Democratic Republic of the Congo (DRC).
Throughout the 42-day period, health authorities maintained enhanced nationwide surveillance and found no evidence of further transmission.
Leishmaniasis is endemic in 80 countries, with an estimated 50,000 to 90,000 new cases reported annually, although WHO estimates that only 25% to 45% of infections are officially documented.
Under the proposed PPP structure, the Egyptian-Turkish consortium will oversee the project’s construction and non-medical operations.
Africa CDC developed the resource through its Hepatitis B Group of Experts, in collaboration with the Centre for Operational Research on Hepatitis B, HEPSANET and the Society for the Study of Liver Disease in Africa.
The approval provides consumers with an additional non-prescription option for managing common types of temporary pain.
The milestone also makes Qatar the third country worldwide to administer Itvisma and marks a significant step in the country’s precision medicine and rare disease care efforts.
The hospital has introduced the MONARCH™ platform, which allows physicians to navigate a flexible endoscope deep into the lungs with greater stability, control and precision.
The network plans to scale diabetes care using a “clinic within a clinic” approach, enabling patients to access integrated and convenient services for chronic disease management.